Recompensation in Cirrhosis: Current Evidence and Future Directions

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• The natural history of cirrhosis traditionally follows a unidirectional path from compensated to decompensated stages.
• An emerging understanding suggests a subset of patients with cirrhosis may experience recompensation, a reversal of disease progression.
• Existing literature on cirrhosis recompensation is limited, often derived from transplant waitlist registries, and lacks explicit definition.

Purpose of the Study:

• To summarize the current literature on the controversial concept of recompensation in cirrhosis.
• To explore the nuances and limitations in defining cirrhosis recompensation.
• To discuss the future implications and impact of recompensation on clinical practice.

Main Methods:

• Literature review of studies discussing cirrhosis progression and regression.
• Analysis of data from transplant waitlist registries indicating disease reversal.
• Synthesis of expert opinions and consensus efforts regarding recompensation criteria.

Main Results:

• Evidence suggests that a subgroup of patients with cirrhosis can achieve recompensation, characterized by disease regression.
• Defining and diagnosing recompensation presents challenges due to varying criteria and limited data.
• Transplant waitlist data provides initial insights into the prevalence and characteristics of recompensation.

Conclusions:

• Cirrhosis recompensation represents a significant, albeit controversial, deviation from the traditional disease trajectory.
• Further research is needed to establish clear diagnostic criteria and understand the mechanisms of recompensation.
• Recognizing recompensation has potential implications for patient management, treatment strategies, and prognostic assessments.